The study further demonstrates that the purification quality of CLP is important, especially for analyses of T-cell development. The original phenotypic CLP has recently been refined by addition of positivity for Flk2 5 and now a smaller population of cells including CD27 are shown to contain the T-cell potential. A specific criticism of the CLP as the thymus-seeding cell has been the lack of evidence that CLP can be detected in thymus. The study further challenged the MPP-seeding hypothesis by identifying the presence of a low level of circulating Flk2ϩCD27ϩCLP, thus formally demonstrating that CLPs can be detected in transit, presumably to the thymus. Since CLPs have not yet been detected in thymus, likely due to rapid adoption of DN1 phenotype, this is an important step forward by identifying a missing link. Overall, the study provides important information about the inner potential of the originally defined CLP and offers additional markers to help all labs standardize their CLP isolations. Let's hope that these advances will help to resolve the thymic progenitor debate.
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Fractalkine: one chemokine, many functions ----------------------------------------------------------------------------------------------------------------
Gemma E. White and David R. Greaves UNIVERSITY OF OXFORD CX 3 CL1 (Fractalkine) is an atypical chemokine with a documented role in the development of numerous inflammatory diseases including atherosclerosis. In this issue of Blood, Landsman and colleagues demonstrate that interactions between CX 3 CL1 and its receptor CX 3 CR1 are involved in monocyte survival via antiapoptotic mechanisms and thus promote atherogenesis. C hemokines (chemotactic cytokines) are a family of low molecular weight proteins which function to coordinate leukocyte trafficking in health and disease. Divided on the basis of structure into 4 families (C, CC, CXC, and CX 3 C), chemokines signal through G protein-coupled 7-transmembrane receptors to induce the directed migration of cells along a chemoattractant gradient. CX 3 CL1 is the only member of the CX 3 C family of chemokines and signals through a single G␣i-linked receptor: CX 3 CR1. 1, 2 Cell surface expression of CX 3 CR1 defines 2 circulating monocyte subsets: CX 3 CR1 low cells correspond to the "inflammatory" Gr1 hi (Ly6C hi ) subset in mice and the CD14 ϩϩ CD16 Ϫ subset in humans. 3 The murine Gr1 low (Ly6C low ) subset expresses significantly higher levels of CX 3 CR1 and corresponds to the CD14 ϩ CD16 ϩ monocyte population in humans. CX 3 CL1 is synthesized as a membrane-bound molecule with the chemokine domain presented on a mucin-like stalk which mediates the direct capture of circulating leukocytes, as shown in the figure. 2 Cleavage at the base of this stalk by metalloproteinases generates a soluble chemokine, which functions as a classical chemoattractant. 4 It is becoming increasingly clear that CX 3 CL1, in common with other chemokines, has a wide range of functional roles that contribute to pathology.
Landsman et al demonstrate that under steady state conditions, mice lacking either CX 3 CL1 or CX 3 CR1 (Cx 3 cr1 gfp/gfp ) have significantly fewer circulating monocytes, specifically those of the Gr1 low subset. Furthermore, cotransfer of Cx 3 cr1 gfp/gfp and wild-type bone marrow into wild-type mice results in a selective reduction of circulating Cx 3 cr1 gfp/gfp Gr1 low monocytes. The forced transgenic expression of the antiapoptotic factor Bcl2 in monocytes rescues this phenotype, indicating that the CX 3 CL1-CX 3 CR1 interaction confers a survival signal under homeostatic conditions. In human monocytes, soluble CX 3 CL1 rescues cells from apoptosis induced by serum-deprivation or cytotoxic stress, though this is not confined to a particular subset.
In the apolipoprotein E (Apoe Ϫ/Ϫ ) deficient mouse model of atherosclerosis, the absence of either CX 3 CL1 or CX 3 CR1 reduces total lesion area and plaque macrophage content. 5, 6 Landsman et al demonstrate that transfer of Cx 3 cr1 gfp/gfp bone marrow into Apoe Ϫ/Ϫ recipients results in reduced atherosclerotic plaque burden (compared with transfer of Cx 3 cr1 ϩ/ϩ bone marrow), and these mice have reduced levels of circulating Gr1 low monocytes. In addition, plaques from these animals contain increased levels of TUNEL ϩ apoptotic cells, consistent with a role for CX 3 CR1 in preventing apoptosis. However, enforced survival of monocytes and plaque foam cells in these mice restore atherosclerosis to levels seen in CX 3 CR1-proficient animals. These data suggest that plaque resident cells depend on the CX 3 CL1-CX 3 CR1 interaction for their survival, providing a plausible mechanism for the proatherogenic function of CX 3 CL1.
However, the role of CX 3 CL1 in controlling levels of circulating monocytes remains controversial. A recently published study failed to show an effect of CX 3 CL1 deficiency on levels of total blood monocytes or individual subsets in Apoe Ϫ/Ϫ mice. 7 Instead, CCR2 deficiency reduced circulating monocyte numbers, and this was not further diminished in Ccr2 Ϫ/Ϫ Cx 3 cl1 Ϫ/Ϫ animals. A second study found significantly reduced levels of circulating Gr1 low monocytes in Cx 3 cr1 Ϫ/Ϫ mice in both homeostatic and inflammatory (Apoe Ϫ/Ϫ ) conditions. 8 However, CCL2 deficiency caused a more marked reduction in blood monocytes while Ccl2 Ϫ/Ϫ Cx 3 cr1 Ϫ/Ϫ Apoe Ϫ/Ϫ mice showed an additive reduction in total and individual monocyte subsets. Landsman et al provide a mechanistic explanation for the effect of CX 3 CL1 on circulating levels of specific monocyte subsets, but this 
Does this study have any implications for targeting chemokines in cardiovascular disease? One key question is whether long-term inhibition of a single chemokine/ receptor would be an effective therapeutic strategy. Combined inhibition of both CCL2 and CX 3 CL1 may be required to overcome redundancy in the chemokine network, but the resultant chronic monocyte suppression could have significant undesirable effects. Although targeting CX 3 CL1 in early atherosclerosis might reduce monocyte accumulation and survival in fatty streak lesions, macrophage survival may be crucial in late disease stages to ensure clearance of necrotic and potentially thrombogenic material. The study presented here adds to our appreciation of CX 3 CL1 as an unusual chemokine and reminds us that chemokines, originally discovered and named for their role in cell migration, have a plethora of functions that are only now being revealed. 
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